Better Collective A/S
BTRCF News Today: Stay Updated with the Latest Better Collective A/S News in Real Time
Find BTRCF news now at Meyka AI. Stay informed with the latest Better Collective A/S stocks updates, including price news, market analysis, and expert insights.
QBTS Stock Today: Record Revenue, $355M Loss; Shares Firmer — February 27
D-Wave Quantum stock rises after record 2025 revenue despite a $355M net loss. We cover QBTS price ($20.14, +2.5%), key metrics, technical levels, analyst views, and what German investors should watch
JPY 791.00 pre-market 28 Feb 2026: IMAGICA (6879.T JPX) oversold bounce watch
Pre-market update on 6879.T stock at JPY 791.00 with oversold bounce setup and model forecast
China Come Ride 8039.HK HKSE pre-market 28 Feb 2026: Oversold bounce at HK$0.15
8039.HK stock pre-market snapshot and oversold bounce outlook at HK$0.151 with Meyka AI analysis
IQL.DE iQ International AG (XETRA) +125% After Hours 27 Feb 2026: outlook
IQL.DE stock jumps +125% to €0.045 after hours on 27 Feb 2026. Low liquidity and Meyka AI forecast included
Earnings due Mar 2: BIRG.IR Bank of Ireland (Euronext) after-hours 27 Feb 2026
After-hours earnings preview for BIRG.IR stock on Euronext; Meyka AI forecasts EUR 22.13 yearly target and flags catalysts
CHF19.28 after-hours 27 Feb: Wacker Neuson SE (WAC.SW SIX) oversold bounce
WAC.SW stock fell to CHF19.28 after-hours; we examine the oversold bounce setup, valuation and targets
February 27: ING’s 3.5% Offer Triggers Germany Savings Rate Race
ING savings account interest jumps to 3.5% for business clients, igniting Germany’s rate race. Consorsbank offers 3.4% for retail, Postbank 2.8%. What it means for savers and investors.
Flu Shots Policy: U.S. Joins WHO Strain Pick Virtually — February 27
WHO finalized 2026–27 WHO flu vaccine strains with CDC experts joining virtually. What this means for U.S. flu shots policy, demand, and vaccine makers outlook (SNY, GSK, MRNA).
CALN.SW Stock Today: February 27 — Buyback, Margin Beat Lift Outlook
Calida stock rises as EBIT doubles to CHF 9m despite a 6.6% sales drop. A 2% buyback starts 9 March and dividend is cut to CHF 0.25. Focus shifts to a >6% EBIT-margin target and the Cosabella review.